Evogene Ownership 2024 | Who Owns Evogene Now?
Institutional Ownership
7.75%
Insider Ownership
1.66%
Retail Ownership
90.59%
Institutional Holders
26.00
Evogene Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 6.08% | 0.47% | 3,079,739 | -5,764 | -0.19% | 2,003,062 | Jun 30, 2024 |
| MORGAN STANLEY | 0.43% | - | 218,455 | -65,593 | -23.09% | 142,083 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.20% | 0.00% | 100,391 | 8,991 | 9.84% | 65,294 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.13% | - | 67,335 | 500 | 0.75% | 43,795 | Jun 30, 2024 |
| UBS GROUP AG | 0.13% | - | 66,005 | 3,510 | 5.62% | 42,903 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.12% | - | 59,007 | - | - | 38,378 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.09% | - | 44,700 | -100 | -0.22% | 29,073 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.08% | - | 38,034 | - | - | 24,722 | Jun 30, 2024 |
| JOEL ISAACSON & CO., LLC | 0.06% | 0.00% | 30,300 | - | - | 19,707 | Jun 30, 2024 |
| SIGMA PLANNING CORP | 0.04% | 0.00% | 22,775 | -9,010 | -28.35% | 14,813 | Jun 30, 2024 |
| CSENGE ADVISORY GROUP | 0.04% | 0.00% | 20,762 | -10,000 | -32.51% | 13,504 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.03% | 0.00% | 15,205 | 3,644 | 31.52% | 9,889 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.03% | - | 14,969 | -24,461 | -62.04% | 9,736 | Jun 30, 2024 |
| PRIVATE ADVISOR GROUP, LLC | 0.03% | 0.00% | 14,013 | - | - | 9,115 | Jun 30, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP LTD. | 0.03% | 0.00% | 13,321 | - | - | 8,664 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.03% | 0.00% | 13,145 | 13,145 | 100.00% | 8,550 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.01% | - | 6,385 | 5,311 | 494.51% | 4,150 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.01% | - | 5,400 | -3,025 | -35.91% | 3,402 | Jun 30, 2024 |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 0.01% | - | 5,000 | - | - | 3,252 | Jun 30, 2024 |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 0.01% | - | 5,000 | - | - | 3,250 | Jun 30, 2024 |
Evogene's largest institutional shareholder is SILVERARC CAPITAL MANAGEMENT, LLC, holding 6.08% of the company's total share outstanding, currently valued at $2.00M. The top 10 institutional shareholders own together 7.36% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 6.08% | 0.47% | 3,079,739 | -5,764 | -0.19% | 2,003,062 | Jun 30, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP LTD. | 0.03% | 0.00% | 13,321 | - | - | 8,664 | Jun 30, 2024 |
| JOEL ISAACSON & CO., LLC | 0.06% | 0.00% | 30,300 | - | - | 19,707 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.03% | 0.00% | 15,205 | 3,644 | 31.52% | 9,889 | Jun 30, 2024 |
| CSENGE ADVISORY GROUP | 0.04% | 0.00% | 20,762 | -10,000 | -32.51% | 13,504 | Jun 30, 2024 |
| SIGMA PLANNING CORP | 0.04% | 0.00% | 22,775 | -9,010 | -28.35% | 14,813 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.03% | 0.00% | 13,145 | 13,145 | 100.00% | 8,550 | Jun 30, 2024 |
| PRIVATE ADVISOR GROUP, LLC | 0.03% | 0.00% | 14,013 | - | - | 9,115 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.20% | 0.00% | 100,391 | 8,991 | 9.84% | 65,294 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.09% | - | 44,700 | -100 | -0.22% | 29,073 | Jun 30, 2024 |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 0.01% | - | 5,000 | - | - | 3,252 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.13% | - | 67,335 | 500 | 0.75% | 43,795 | Jun 30, 2024 |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 0.01% | - | 5,000 | - | - | 3,250 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.08% | - | 38,034 | - | - | 24,722 | Jun 30, 2024 |
| MORGAN STANLEY | 0.43% | - | 218,455 | -65,593 | -23.09% | 142,083 | Jun 30, 2024 |
| UBS GROUP AG | 0.13% | - | 66,005 | 3,510 | 5.62% | 42,903 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.01% | - | 5,400 | -3,025 | -35.91% | 3,402 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.12% | - | 59,007 | - | - | 38,378 | Jun 30, 2024 |
| COPPELL ADVISORY SOLUTIONS LLC | 0.00% | - | 27 | 27 | 100.00% | 18 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.03% | - | 14,969 | -24,461 | -62.04% | 9,736 | Jun 30, 2024 |
The largest Evogene shareholder by % of total assets is SILVERARC CAPITAL MANAGEMENT, LLC. The company owns 3.08M shares of Evogene (EVGN), representing 0.47% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TWO SIGMA SECURITIES, LLC | 0.03% | 0.00% | 13,145 | 13,145 | 100.00% | 8,550 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.20% | 0.00% | 100,391 | 8,991 | 9.84% | 65,294 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.01% | - | 6,385 | 5,311 | 494.51% | 4,150 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.03% | 0.00% | 15,205 | 3,644 | 31.52% | 9,889 | Jun 30, 2024 |
| UBS GROUP AG | 0.13% | - | 66,005 | 3,510 | 5.62% | 42,903 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.13% | - | 67,335 | 500 | 0.75% | 43,795 | Jun 30, 2024 |
| COPPELL ADVISORY SOLUTIONS LLC | 0.00% | - | 27 | 27 | 100.00% | 18 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 50 | - | - | 33 | Jun 30, 2024 |
| TORONTO DOMINION BANK | - | - | 20 | - | - | 130 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.12% | - | 59,007 | - | - | 38,378 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.08% | - | 38,034 | - | - | 24,722 | Jun 30, 2024 |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 0.01% | - | 5,000 | - | - | 3,250 | Jun 30, 2024 |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 0.01% | - | 5,000 | - | - | 3,252 | Jun 30, 2024 |
| PRIVATE ADVISOR GROUP, LLC | 0.03% | 0.00% | 14,013 | - | - | 9,115 | Jun 30, 2024 |
| JOEL ISAACSON & CO., LLC | 0.06% | 0.00% | 30,300 | - | - | 19,707 | Jun 30, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP LTD. | 0.03% | 0.00% | 13,321 | - | - | 8,664 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.09% | - | 44,700 | -100 | -0.22% | 29,073 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -126 | -100.00% | - | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.01% | - | 5,400 | -3,025 | -35.91% | 3,402 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 6.08% | 0.47% | 3,079,739 | -5,764 | -0.19% | 2,003,062 | Jun 30, 2024 |
As of Jun 30 2024, Evogene's largest institutional buyer is TWO SIGMA SECURITIES, LLC. The company purchased 13.14K stocks of EVGN, valued at $8.55K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MORGAN STANLEY | 0.43% | - | 218,455 | -65,593 | -23.09% | 142,083 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.03% | - | 14,969 | -24,461 | -62.04% | 9,736 | Jun 30, 2024 |
| MALAGA COVE CAPITAL, LLC | - | - | - | -12,000 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -11,524 | -100.00% | - | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | - | - | - | -11,089 | -100.00% | - | Jun 30, 2024 |
| CSENGE ADVISORY GROUP | 0.04% | 0.00% | 20,762 | -10,000 | -32.51% | 13,504 | Jun 30, 2024 |
| SIGMA PLANNING CORP | 0.04% | 0.00% | 22,775 | -9,010 | -28.35% | 14,813 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 6.08% | 0.47% | 3,079,739 | -5,764 | -0.19% | 2,003,062 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.01% | - | 5,400 | -3,025 | -35.91% | 3,402 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -126 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.09% | - | 44,700 | -100 | -0.22% | 29,073 | Jun 30, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP LTD. | 0.03% | 0.00% | 13,321 | - | - | 8,664 | Jun 30, 2024 |
| JOEL ISAACSON & CO., LLC | 0.06% | 0.00% | 30,300 | - | - | 19,707 | Jun 30, 2024 |
| PRIVATE ADVISOR GROUP, LLC | 0.03% | 0.00% | 14,013 | - | - | 9,115 | Jun 30, 2024 |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 0.01% | - | 5,000 | - | - | 3,252 | Jun 30, 2024 |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 0.01% | - | 5,000 | - | - | 3,250 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.08% | - | 38,034 | - | - | 24,722 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.12% | - | 59,007 | - | - | 38,378 | Jun 30, 2024 |
| TORONTO DOMINION BANK | - | - | 20 | - | - | 130 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 50 | - | - | 33 | Jun 30, 2024 |
As of Jun 30 2024, Evogene's biggest institutional seller is MORGAN STANLEY. The company sold -65.59K shares of EVGN, valued at $142.08K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| COPPELL ADVISORY SOLUTIONS LLC | 0.00% | - | 27 | 27 | 100.00% | 18 | Jun 30, 2024 |
Evogene's largest new institutional shareholder by number of shares is COPPELL ADVISORY SOLUTIONS LLC, purchased 27.00 shares, valued at $18.00, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MALAGA COVE CAPITAL, LLC | - | - | - | -12,000 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -11,524 | -100.00% | - | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | - | - | - | -11,089 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -126 | -100.00% | - | Jun 30, 2024 |
Evogene's largest sold out institutional shareholder by shares sold is MALAGA COVE CAPITAL, LLC, sold -12.00K shares, valued at -, as of undefined.
Evogene Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 3,768 | - | - | Mar 31, 2024 |
Evogene's largest mutual fund holder by % of total assets is "JOHN HANCOCK VARIABLE INSURANCE TRUST", owning 3.77K shares, compromising 0.00% of its total assets.
Evogene Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 26 | -7.14% |
| 31 Mar, 24 | 28 | -12.50% |
| 31 Dec, 23 | 32 | -3.03% |
| 30 Sep, 23 | 33 | 26.92% |
| 30 Jun, 23 | 26 | - |
| 31 Mar, 23 | 26 | -7.14% |
| 31 Dec, 22 | 28 | 16.67% |
| 30 Sep, 22 | 24 | -14.29% |
| 30 Jun, 22 | 28 | -24.32% |
| 31 Mar, 22 | 37 | -9.76% |
| 31 Dec, 21 | 41 | -2.38% |
| 30 Sep, 21 | 42 | -8.70% |
| 30 Jun, 21 | 46 | -9.80% |
| 31 Mar, 21 | 51 | 59.38% |
| 31 Dec, 20 | 32 | 88.24% |
| 30 Sep, 20 | 17 | 6.25% |
| 30 Jun, 20 | 16 | 6.67% |
| 31 Mar, 20 | 15 | - |
| 31 Dec, 19 | 15 | -11.76% |
| 30 Sep, 19 | 17 | - |
| 30 Jun, 19 | 17 | -19.05% |
| 31 Mar, 19 | 21 | -8.70% |
| 31 Dec, 18 | 23 | - |
| 30 Sep, 18 | 23 | - |
| 30 Jun, 18 | 23 | -8.00% |
| 31 Mar, 18 | 25 | 4.17% |
| 31 Dec, 17 | 24 | 33.33% |
| 30 Sep, 17 | 18 | -14.29% |
| 30 Jun, 17 | 21 | -4.55% |
| 31 Mar, 17 | 22 | - |
| 31 Dec, 16 | 22 | 22.22% |
| 30 Sep, 16 | 18 | - |
| 30 Jun, 16 | 18 | -14.29% |
| 31 Mar, 16 | 21 | 10.53% |
| 31 Dec, 15 | 19 | 5.56% |
| 30 Sep, 15 | 18 | - |
| 30 Jun, 15 | 18 | 12.50% |
| 31 Mar, 15 | 16 | 6.67% |
| 31 Dec, 14 | 15 | - |
| 30 Sep, 14 | 15 | - |
| 30 Jun, 14 | 15 | -16.67% |
| 31 Mar, 14 | 18 | 5.88% |
| 31 Dec, 13 | 17 | - |
As of 30 Jun 24, 26 institutions are holding Evogene's shares, representing a decrease of -7.14% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 3,925,099 | -3.08% |
| 31 Mar, 24 | 4,050,008 | -7.80% |
| 31 Dec, 23 | 4,392,706 | 0.02% |
| 30 Sep, 23 | 4,392,025 | 528.20% |
| 30 Jun, 23 | 699,139 | -11.03% |
| 31 Mar, 23 | 785,848 | -27.39% |
| 31 Dec, 22 | 1,082,269 | -24.95% |
| 30 Sep, 22 | 1,442,075 | -7.84% |
| 30 Jun, 22 | 1,564,836 | -34.79% |
| 31 Mar, 22 | 2,399,851 | -59.84% |
| 31 Dec, 21 | 5,975,466 | -4.40% |
| 30 Sep, 21 | 6,250,166 | -15.14% |
| 30 Jun, 21 | 7,365,319 | -11.78% |
| 31 Mar, 21 | 8,348,976 | -12.52% |
| 31 Dec, 20 | 9,543,796 | 12.37% |
| 30 Sep, 20 | 8,493,483 | 37.07% |
| 30 Jun, 20 | 6,196,365 | -15.26% |
| 31 Mar, 20 | 7,312,420 | 8.55% |
| 31 Dec, 19 | 6,736,377 | -10.44% |
| 30 Sep, 19 | 7,521,386 | -0.08% |
| 30 Jun, 19 | 7,527,241 | -13.25% |
| 31 Mar, 19 | 8,676,785 | -4.81% |
| 31 Dec, 18 | 9,115,525 | 0.23% |
| 30 Sep, 18 | 9,094,703 | 0.30% |
| 30 Jun, 18 | 9,067,253 | -1.47% |
| 31 Mar, 18 | 9,202,857 | -0.20% |
| 31 Dec, 17 | 9,220,844 | 15.74% |
| 30 Sep, 17 | 7,966,801 | -0.76% |
| 30 Jun, 17 | 8,027,421 | 2.84% |
| 31 Mar, 17 | 7,805,502 | 1.31% |
| 31 Dec, 16 | 7,704,367 | 1.28% |
| 30 Sep, 16 | 7,606,646 | 1.61% |
| 30 Jun, 16 | 7,486,335 | 2.04% |
| 31 Mar, 16 | 7,336,690 | 4.07% |
| 31 Dec, 15 | 7,049,473 | 10.48% |
| 30 Sep, 15 | 6,380,810 | 1.92% |
| 30 Jun, 15 | 6,260,311 | 5.66% |
| 31 Mar, 15 | 5,925,046 | 4.97% |
| 31 Dec, 14 | 5,644,727 | 13.97% |
| 30 Sep, 14 | 4,952,851 | 21.13% |
| 30 Jun, 14 | 4,088,931 | -0.58% |
| 31 Mar, 14 | 4,112,706 | -15.61% |
| 31 Dec, 13 | 4,873,504 | - |
Evogene (EVGN) has 3.93M shares outstanding as of 30 Jun 24, down -3.08% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 7.75% | 12.10% |
| 31 Mar, 24 | 8.01% | 9.93% |
| 31 Dec, 23 | 8.98% | 8.07% |
| 30 Sep, 23 | 10.55% | 371.41% |
| 30 Jun, 23 | 1.69% | 46.97% |
| 31 Mar, 23 | 1.89% | 27.46% |
| 31 Dec, 22 | 2.63% | 21.45% |
| 30 Sep, 22 | 3.50% | 24.25% |
| 30 Jun, 22 | 3.80% | 11.19% |
| 31 Mar, 22 | 5.83% | 2.77% |
| 31 Dec, 21 | 14.51% | 6.20% |
| 30 Sep, 21 | 15.30% | 4.65% |
| 30 Jun, 21 | 18.15% | 3.95% |
| 31 Mar, 21 | 21.43% | 2.74% |
| 31 Dec, 20 | 27.98% | 2.82% |
| 30 Sep, 20 | 31.48% | 5.44% |
| 30 Jun, 20 | 24.06% | 2.98% |
| 31 Mar, 20 | 28.39% | 4.15% |
| 31 Dec, 19 | 26.16% | 3.07% |
| 30 Sep, 19 | 29.20% | 3.42% |
| 30 Jun, 19 | 29.23% | 2.57% |
| 31 Mar, 19 | 33.69% | 2.69% |
| 31 Dec, 18 | 35.40% | 2.84% |
| 30 Sep, 18 | 35.31% | 2.85% |
| 30 Jun, 18 | 35.21% | 2.76% |
| 31 Mar, 18 | 35.74% | 2.78% |
| 31 Dec, 17 | 35.84% | 3.56% |
| 30 Sep, 17 | 31.71% | 3.42% |
| 30 Jun, 17 | 30.46% | 3.25% |
| 31 Mar, 17 | 30.60% | 3.37% |
| 31 Dec, 16 | 30.15% | 3.41% |
| 30 Sep, 16 | 29.75% | 3.26% |
| 30 Jun, 16 | 30.19% | 3.77% |
| 31 Mar, 16 | 28.29% | 3.65% |
| 31 Dec, 15 | 27.85% | 4.63% |
| 30 Sep, 15 | 24.53% | 3.83% |
| 30 Jun, 15 | 25.29% | 4.95% |
| 31 Mar, 15 | 22.59% | 4.45% |
| 31 Dec, 14 | 22.53% | 5.55% |
| 30 Sep, 14 | 20.15% | 7.26% |
| 30 Jun, 14 | 16.66% | 6.09% |
| 31 Mar, 14 | 16.54% | 3.10% |
| 31 Dec, 13 | 23.11% | - |
As of 30 Jun 24, Evogene is held by 7.75% institutional shareholders, representing a 12.10% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 8 | -27.27% |
| 31 Mar, 24 | 11 | 37.50% |
| 31 Dec, 23 | 8 | -55.56% |
| 30 Sep, 23 | 18 | 50.00% |
| 30 Jun, 23 | 12 | 50.00% |
| 31 Mar, 23 | 8 | -27.27% |
| 31 Dec, 22 | 11 | 57.14% |
| 30 Sep, 22 | 7 | - |
| 30 Jun, 22 | 7 | -36.36% |
| 31 Mar, 22 | 11 | -47.62% |
| 31 Dec, 21 | 21 | 90.91% |
| 30 Sep, 21 | 11 | -42.11% |
| 30 Jun, 21 | 19 | -44.12% |
| 31 Mar, 21 | 34 | 30.77% |
| 31 Dec, 20 | 26 | 116.67% |
| 30 Sep, 20 | 12 | 71.43% |
| 30 Jun, 20 | 7 | 40.00% |
| 31 Mar, 20 | 5 | 400.00% |
| 31 Dec, 19 | 1 | -80.00% |
| 30 Sep, 19 | 5 | 25.00% |
| 30 Jun, 19 | 4 | -50.00% |
| 31 Mar, 19 | 8 | 14.29% |
| 31 Dec, 18 | 7 | -22.22% |
| 30 Sep, 18 | 9 | 12.50% |
| 30 Jun, 18 | 8 | 14.29% |
| 31 Mar, 18 | 7 | -50.00% |
| 31 Dec, 17 | 14 | 100.00% |
| 30 Sep, 17 | 7 | - |
| 30 Jun, 17 | 7 | -22.22% |
| 31 Mar, 17 | 9 | -10.00% |
| 31 Dec, 16 | 10 | 66.67% |
| 30 Sep, 16 | 6 | -14.29% |
| 30 Jun, 16 | 7 | -36.36% |
| 31 Mar, 16 | 11 | - |
| 31 Dec, 15 | 11 | 22.22% |
| 30 Sep, 15 | 9 | 12.50% |
| 30 Jun, 15 | 8 | 60.00% |
| 31 Mar, 15 | 5 | -28.57% |
| 31 Dec, 14 | 7 | 16.67% |
| 30 Sep, 14 | 6 | 100.00% |
| 30 Jun, 14 | 3 | -50.00% |
| 31 Mar, 14 | 6 | -64.71% |
| 31 Dec, 13 | 17 | - |
8 institutional shareholders have increased their position in EVGN stock as of 30 Jun 24 compared to 11 in the previous quarter (a -27.27% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 8 | 100.00% |
| 31 Mar, 24 | 4 | -42.86% |
| 31 Dec, 23 | 7 | 75.00% |
| 30 Sep, 23 | 4 | -20.00% |
| 30 Jun, 23 | 5 | -28.57% |
| 31 Mar, 23 | 7 | 40.00% |
| 31 Dec, 22 | 5 | - |
| 30 Sep, 22 | 5 | -58.33% |
| 30 Jun, 22 | 12 | 9.09% |
| 31 Mar, 22 | 11 | 22.22% |
| 31 Dec, 21 | 9 | -52.63% |
| 30 Sep, 21 | 19 | 18.75% |
| 30 Jun, 21 | 16 | 220.00% |
| 31 Mar, 21 | 5 | 25.00% |
| 31 Dec, 20 | 4 | -20.00% |
| 30 Sep, 20 | 5 | 25.00% |
| 30 Jun, 20 | 4 | 100.00% |
| 31 Mar, 20 | 2 | -71.43% |
| 31 Dec, 19 | 7 | 133.33% |
| 30 Sep, 19 | 3 | -50.00% |
| 30 Jun, 19 | 6 | 20.00% |
| 31 Mar, 19 | 5 | 25.00% |
| 31 Dec, 18 | 4 | 33.33% |
| 30 Sep, 18 | 3 | - |
| 30 Jun, 18 | 3 | -57.14% |
| 31 Mar, 18 | 7 | 250.00% |
| 31 Dec, 17 | 2 | - |
| 30 Sep, 17 | 2 | -33.33% |
| 30 Jun, 17 | 3 | -25.00% |
| 31 Mar, 17 | 4 | -20.00% |
| 31 Dec, 16 | 5 | 66.67% |
| 30 Sep, 16 | 3 | - |
| 30 Jun, 16 | 3 | -40.00% |
| 31 Mar, 16 | 5 | - |
| 31 Dec, 15 | - | -100.00% |
| 30 Sep, 15 | 2 | - |
| 30 Jun, 15 | 2 | -33.33% |
| 31 Mar, 15 | 3 | -25.00% |
| 31 Dec, 14 | 4 | -20.00% |
| 30 Sep, 14 | 5 | -28.57% |
| 30 Jun, 14 | 7 | -22.22% |
| 31 Mar, 14 | 9 | - |
| 31 Dec, 13 | - | - |
8 institutional shareholders have reduced their position in EVGN stock as of 30 Jun 24 compared to 4 in the previous quarter (a 100.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 26 | -7.14% | 3,925,099 | -3.08% | 7.75% | 12.10% | 8 | -27.27% | 8 | 100.00% |
| 31 Mar, 24 | 28 | -12.50% | 4,050,008 | -7.80% | 8.01% | 9.93% | 11 | 37.50% | 4 | -42.86% |
| 31 Dec, 23 | 32 | -3.03% | 4,392,706 | 0.02% | 8.98% | 8.07% | 8 | -55.56% | 7 | 75.00% |
| 30 Sep, 23 | 33 | 26.92% | 4,392,025 | 528.20% | 10.55% | 371.41% | 18 | 50.00% | 4 | -20.00% |
| 30 Jun, 23 | 26 | - | 699,139 | -11.03% | 1.69% | 46.97% | 12 | 50.00% | 5 | -28.57% |
| 31 Mar, 23 | 26 | -7.14% | 785,848 | -27.39% | 1.89% | 27.46% | 8 | -27.27% | 7 | 40.00% |
| 31 Dec, 22 | 28 | 16.67% | 1,082,269 | -24.95% | 2.63% | 21.45% | 11 | 57.14% | 5 | - |
| 30 Sep, 22 | 24 | -14.29% | 1,442,075 | -7.84% | 3.50% | 24.25% | 7 | - | 5 | -58.33% |
| 30 Jun, 22 | 28 | -24.32% | 1,564,836 | -34.79% | 3.80% | 11.19% | 7 | -36.36% | 12 | 9.09% |
| 31 Mar, 22 | 37 | -9.76% | 2,399,851 | -59.84% | 5.83% | 2.77% | 11 | -47.62% | 11 | 22.22% |
| 31 Dec, 21 | 41 | -2.38% | 5,975,466 | -4.40% | 14.51% | 6.20% | 21 | 90.91% | 9 | -52.63% |
| 30 Sep, 21 | 42 | -8.70% | 6,250,166 | -15.14% | 15.30% | 4.65% | 11 | -42.11% | 19 | 18.75% |
| 30 Jun, 21 | 46 | -9.80% | 7,365,319 | -11.78% | 18.15% | 3.95% | 19 | -44.12% | 16 | 220.00% |
| 31 Mar, 21 | 51 | 59.38% | 8,348,976 | -12.52% | 21.43% | 2.74% | 34 | 30.77% | 5 | 25.00% |
| 31 Dec, 20 | 32 | 88.24% | 9,543,796 | 12.37% | 27.98% | 2.82% | 26 | 116.67% | 4 | -20.00% |
| 30 Sep, 20 | 17 | 6.25% | 8,493,483 | 37.07% | 31.48% | 5.44% | 12 | 71.43% | 5 | 25.00% |
| 30 Jun, 20 | 16 | 6.67% | 6,196,365 | -15.26% | 24.06% | 2.98% | 7 | 40.00% | 4 | 100.00% |
| 31 Mar, 20 | 15 | - | 7,312,420 | 8.55% | 28.39% | 4.15% | 5 | 400.00% | 2 | -71.43% |
| 31 Dec, 19 | 15 | -11.76% | 6,736,377 | -10.44% | 26.16% | 3.07% | 1 | -80.00% | 7 | 133.33% |
| 30 Sep, 19 | 17 | - | 7,521,386 | -0.08% | 29.20% | 3.42% | 5 | 25.00% | 3 | -50.00% |
| 30 Jun, 19 | 17 | -19.05% | 7,527,241 | -13.25% | 29.23% | 2.57% | 4 | -50.00% | 6 | 20.00% |
| 31 Mar, 19 | 21 | -8.70% | 8,676,785 | -4.81% | 33.69% | 2.69% | 8 | 14.29% | 5 | 25.00% |
| 31 Dec, 18 | 23 | - | 9,115,525 | 0.23% | 35.40% | 2.84% | 7 | -22.22% | 4 | 33.33% |
| 30 Sep, 18 | 23 | - | 9,094,703 | 0.30% | 35.31% | 2.85% | 9 | 12.50% | 3 | - |
| 30 Jun, 18 | 23 | -8.00% | 9,067,253 | -1.47% | 35.21% | 2.76% | 8 | 14.29% | 3 | -57.14% |
| 31 Mar, 18 | 25 | 4.17% | 9,202,857 | -0.20% | 35.74% | 2.78% | 7 | -50.00% | 7 | 250.00% |
| 31 Dec, 17 | 24 | 33.33% | 9,220,844 | 15.74% | 35.84% | 3.56% | 14 | 100.00% | 2 | - |
| 30 Sep, 17 | 18 | -14.29% | 7,966,801 | -0.76% | 31.71% | 3.42% | 7 | - | 2 | -33.33% |
| 30 Jun, 17 | 21 | -4.55% | 8,027,421 | 2.84% | 30.46% | 3.25% | 7 | -22.22% | 3 | -25.00% |
| 31 Mar, 17 | 22 | - | 7,805,502 | 1.31% | 30.60% | 3.37% | 9 | -10.00% | 4 | -20.00% |
| 31 Dec, 16 | 22 | 22.22% | 7,704,367 | 1.28% | 30.15% | 3.41% | 10 | 66.67% | 5 | 66.67% |
| 30 Sep, 16 | 18 | - | 7,606,646 | 1.61% | 29.75% | 3.26% | 6 | -14.29% | 3 | - |
| 30 Jun, 16 | 18 | -14.29% | 7,486,335 | 2.04% | 30.19% | 3.77% | 7 | -36.36% | 3 | -40.00% |
| 31 Mar, 16 | 21 | 10.53% | 7,336,690 | 4.07% | 28.29% | 3.65% | 11 | - | 5 | - |
| 31 Dec, 15 | 19 | 5.56% | 7,049,473 | 10.48% | 27.85% | 4.63% | 11 | 22.22% | - | -100.00% |
| 30 Sep, 15 | 18 | - | 6,380,810 | 1.92% | 24.53% | 3.83% | 9 | 12.50% | 2 | - |
| 30 Jun, 15 | 18 | 12.50% | 6,260,311 | 5.66% | 25.29% | 4.95% | 8 | 60.00% | 2 | -33.33% |
| 31 Mar, 15 | 16 | 6.67% | 5,925,046 | 4.97% | 22.59% | 4.45% | 5 | -28.57% | 3 | -25.00% |
| 31 Dec, 14 | 15 | - | 5,644,727 | 13.97% | 22.53% | 5.55% | 7 | 16.67% | 4 | -20.00% |
| 30 Sep, 14 | 15 | - | 4,952,851 | 21.13% | 20.15% | 7.26% | 6 | 100.00% | 5 | -28.57% |
| 30 Jun, 14 | 15 | -16.67% | 4,088,931 | -0.58% | 16.66% | 6.09% | 3 | -50.00% | 7 | -22.22% |
| 31 Mar, 14 | 18 | 5.88% | 4,112,706 | -15.61% | 16.54% | 3.10% | 6 | -64.71% | 9 | - |
| 31 Dec, 13 | 17 | - | 4,873,504 | - | 23.11% | - | 17 | - | - | - |
Evogene Peer Ownership
| Ticker | Company |
|---|---|
| ZVSA | ZyVersa Therapeutics, Inc. |
| CKPT | Checkpoint Therapeutics, Inc. |
| BDRX | Biodexa Pharmaceuticals Plc |
| GMDA | Gamida Cell Ltd. |
| ONCR | Oncorus, Inc. |
| LEXX | Lexaria Bioscience Corp. |
| SURF | Surface Oncology, Inc. |
| FATE | Fate Therapeutics, Inc. |
| ALDX | Aldeyra Therapeutics, Inc. |
| RCUS | Arcus Biosciences, Inc. |
| PLUR | Pluri Inc. |
| CLGN | CollPlant Biotechnologies Ltd. |
| CRVS | Corvus Pharmaceuticals, Inc. |
| CGEN | Compugen Ltd. |
| ICCC | ImmuCell Corporation |
EVGN Ownership FAQ
Who Owns Evogene?
Evogene is owned by institutional shareholders (7.75%), insiders (1.66%), and public (90.59%). The largest institutional shareholder of Evogene is SILVERARC CAPITAL MANAGEMENT, LLC (6.08% of total shares) and the top mutual fund owner is JOHN HANCOCK VARIABLE INSURANCE TRUST (0.00% of total shares).
Who are the major institutional shareholders of Evogene?
Evogene's major institutional shareholders are SILVERARC CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, BNP PARIBAS ARBITRAGE, SNC, LPL FINANCIAL LLC, and UBS GROUP AG. The top five shareholders own together 6.98% of the company's share outstanding.
How many Evogene shareholders are there?
As of Jun 2024, there are 26 institutional shareholders of Evogene.
What percentage of Evogene is owned by SILVERARC CAPITAL MANAGEMENT, LLC?
SILVERARC CAPITAL MANAGEMENT, LLC owns 3.08M shares of Evogene, representing 6.08% of the company's total shares outstanding, valued at $2M (as of Jun 2024).
What percentage of Evogene is owned by MORGAN STANLEY?
As of Jun 2024, MORGAN STANLEY holds 218.46K shares of Evogene (EVGN), compromising 0.43% of the company, valued at $142.08K.
What percentage of Evogene is owned by BNP PARIBAS ARBITRAGE, SNC?
BNP PARIBAS ARBITRAGE, SNC is the third largest holder of Evogene. The company owns 100.39K of the company's shares outstanding (worth $65.29K).